Childhood lymphoma

被引:5
作者
Kevin Windebank
机构
[1] University of Newcastle upon Tyne,Department of Child Health
[2] Royal Victoria Infirmary,undefined
[3] Sir James Spence Institute,undefined
关键词
Lymphoma; Burkitts; Child; Tharapy;
D O I
10.1007/BF02731040
中图分类号
学科分类号
摘要
Lymphoma accounts for some 10% of childhood malignancy. Hodgkins disease is slightly less common than Non Hodgkins lymphoma, of which lymphoblastic, Burkitts and large cell anaplastic are the common subtypes. Accurate subtyping and staging are critical to ensure correct therapy is initiated. With current therapeutic strategies, almost all cases of Hodgkins and in excess of 70% of Non Hodgkins lymphomas can be cured.
引用
收藏
页码:669 / 680
页数:11
相关论文
共 66 条
  • [1] Harris NL(1994)A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group Blood 84 1045-1047
  • [2] Jaffe ES(1998)Lack of invovtement of known oncogenic DNA viruses in Epslein-Barr virus-negative Hodgkin’s disease Brit J Cane 77 1045-1047
  • [3] Stein H(1996)Hodgkin and ReedStemberg cells’in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal centre B cells J Exp Med 184 1495-1505
  • [4] Armstrong AA(1997)Does histology influence outcome in childhood Hodgkin’s disease? Results from the United Kingdom Children’s Cancer Study Group J Clin Onc 15 2622-2630
  • [5] Shield L(1966)The treatment of Hodgkin’s Disease Med Clin North Am 50 1591-1610
  • [6] Gallagher A(1988)Hodgkin’s Disease Pediatric Annds 17 204-223
  • [7] Jarrett RF(1971)Report of the committee on Hodgkin’s disease staging classification Can Res 31 1860-1861
  • [8] Kanzler H; Kuppers R(1970)Combination chemotherapy in the treatment of advanced Hodgkin’s Disease Ann Int Med 73 881-895
  • [9] Hansmann M-L(1977)A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin’;s disease Br J Cane 36 276-280
  • [10] Rajewsky K(1975)Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP Cancer 36 252-259